Mario Varasi

4.3k total citations
83 papers, 2.0k citations indexed

About

Mario Varasi is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Mario Varasi has authored 83 papers receiving a total of 2.0k indexed citations (citations by other indexed papers that have themselves been cited), including 47 papers in Molecular Biology, 26 papers in Organic Chemistry and 13 papers in Oncology. Recurrent topics in Mario Varasi's work include Histone Deacetylase Inhibitors Research (13 papers), Epigenetics and DNA Methylation (12 papers) and Tryptophan and brain disorders (10 papers). Mario Varasi is often cited by papers focused on Histone Deacetylase Inhibitors Research (13 papers), Epigenetics and DNA Methylation (12 papers) and Tryptophan and brain disorders (10 papers). Mario Varasi collaborates with scholars based in Italy, United States and United Kingdom. Mario Varasi's co-authors include Paolo Pevarello, Carmela Speciale, Ciro Mercurio, Patricia Salvati, Keith A. M. Walker, Michael L. Maddox, Robert A. McArthur, Saverio Minucci, Ruggero G. Fariello and Paola Vianello and has published in prestigious journals such as Journal of the American Chemical Society, Molecular Cell and Clinical Cancer Research.

In The Last Decade

Mario Varasi

80 papers receiving 1.9k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Mario Varasi Italy 25 1.0k 556 273 240 213 83 2.0k
Paolo Pevarello Italy 21 859 0.8× 360 0.6× 219 0.8× 79 0.3× 170 0.8× 54 1.6k
Grazia Lombardi Italy 29 1.1k 1.1× 212 0.4× 792 2.9× 239 1.0× 139 0.7× 66 2.3k
Barbara Costa Italy 31 1.2k 1.2× 586 1.1× 565 2.1× 101 0.4× 90 0.4× 111 2.7k
Francesco G. Salituro United States 27 923 0.9× 357 0.6× 462 1.7× 185 0.8× 85 0.4× 45 1.8k
Lawrence P. Wennogle United States 30 1.7k 1.6× 202 0.4× 761 2.8× 131 0.5× 208 1.0× 69 2.6k
Valeria Lucini Italy 32 864 0.8× 619 1.1× 469 1.7× 40 0.2× 154 0.7× 84 2.6k
Shil Patel United States 29 1.3k 1.2× 471 0.8× 1.1k 4.0× 84 0.3× 174 0.8× 59 2.4k
Sabrina Taliani Italy 36 1.8k 1.7× 1.2k 2.2× 490 1.8× 104 0.4× 83 0.4× 145 3.6k
Anna Partyka Poland 26 883 0.9× 539 1.0× 529 1.9× 183 0.8× 154 0.7× 105 1.9k
David J. Wustrow United States 20 746 0.7× 611 1.1× 491 1.8× 39 0.2× 101 0.5× 54 1.7k

Countries citing papers authored by Mario Varasi

Since Specialization
Citations

This map shows the geographic impact of Mario Varasi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Mario Varasi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Mario Varasi more than expected).

Fields of papers citing papers by Mario Varasi

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Mario Varasi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Mario Varasi. The network helps show where Mario Varasi may publish in the future.

Co-authorship network of co-authors of Mario Varasi

This figure shows the co-authorship network connecting the top 25 collaborators of Mario Varasi. A scholar is included among the top collaborators of Mario Varasi based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Mario Varasi. Mario Varasi is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Tobon, Alejandro, Reinald Shyti, Carlo Emanuele Villa, et al.. (2023). GTF2I dosage regulates neuronal differentiation and social behavior in 7q11.23 neurodevelopmental disorders. Science Advances. 9(48). eadh2726–eadh2726. 15 indexed citations
2.
Bello, Elisabetta Di, Clemens Zwergel, Rossella Fioravanti, et al.. (2022). Novel pyridine-containing histone deacetylase inhibitors strongly arrest proliferation, induce apoptosis and modulate miRNAs in cancer cells. European Journal of Medicinal Chemistry. 247. 115022–115022. 13 indexed citations
3.
Pessina, Fabio, et al.. (2022). Enrichment of DNA replication intermediates by EdU pull down. Methods in cell biology. 182. 83–94. 1 indexed citations
4.
Ceccacci, Elena, Amir Hosseini, Iros Barozzi, et al.. (2020). Targeting the scaffolding role of LSD1 (KDM1A) poises acute myeloid leukemia cells for retinoic acid–induced differentiation. Science Advances. 6(15). eaax2746–eaax2746. 59 indexed citations
5.
Zwergel, Clemens, Elisabetta Di Bello, Rossella Fioravanti, et al.. (2020). Novel Pyridine‐Based Hydroxamates and 2′‐Aminoanilides as Histone Deacetylase Inhibitors: Biochemical Profile and Anticancer Activity. ChemMedChem. 16(6). 989–999. 12 indexed citations
6.
Cavallo, Francesca, Flavia Troglio, Giovanni Fagà, et al.. (2020). High-throughput screening identifies histone deacetylase inhibitors that modulate GTF2I expression in 7q11.23 microduplication autism spectrum disorder patient-derived cortical neurons. Molecular Autism. 11(1). 88–88. 18 indexed citations
7.
Abdel‐Aziz, Amal Kamal, Isabella Pallavicini, Elena Ceccacci, et al.. (2019). Tuning mTORC1 activity dictates the response of acute myeloid leukemia to LSD1 inhibition. Haematologica. 105(8). 2105–2117. 26 indexed citations
8.
Thaler, Florian, Raffaella Amici, Agnese Abate, et al.. (2015). Synthesis, biological characterization and molecular modeling insights of spirochromanes as potent HDAC inhibitors. European Journal of Medicinal Chemistry. 108. 53–67. 28 indexed citations
9.
Vianello, Paola, Oronza A. Botrugno, Giuseppe Ciossani, et al.. (2014). Synthesis, biological activity and mechanistic insights of 1-substituted cyclopropylamine derivatives: A novel class of irreversible inhibitors of histone demethylase KDM1A. European Journal of Medicinal Chemistry. 86. 352–363. 46 indexed citations
10.
Colzani, Mara, Roberta Noberini, Mauro Romanenghi, et al.. (2014). Quantitative Chemical Proteomics Identifies Novel Targets of the Anti-cancer Multi-kinase Inhibitor E-3810. Molecular & Cellular Proteomics. 13(6). 1495–1509. 11 indexed citations
11.
12.
Thaler, Florian, Mario Varasi, Andrea Colombo, et al.. (2010). Synthesis and Biological Characterization of Amidopropenyl Hydroxamates as HDAC Inhibitors. ChemMedChem. 5(8). 1359–1372. 13 indexed citations
13.
Pevarello, Paolo, Daniele Fancelli, Anna Vulpetti, et al.. (2005). 3-Amino-1,4,5,6-tetrahydropyrrolo[3,4-c]pyrazoles: A new class of CDK2 inhibitors. Bioorganic & Medicinal Chemistry Letters. 16(4). 1084–1090. 46 indexed citations
14.
Vianello, Paola, Paolo Cozzi, Arturo Galvani, et al.. (2004). Solid-phase synthesis of a small library of 3-phenylthio-3-nicotinyl propionic acid derivatives acting as antagonists of the integrin αVβ3. Bioorganic & Medicinal Chemistry Letters. 14(3). 657–661. 6 indexed citations
15.
Wu, Hui‐Qiu, Paolo Guidetti, Jeffrey H. Goodman, et al.. (2000). Kynurenergic manipulations influence excitatory synaptic function and excitotoxic vulnerability in the rat hippocampus in vivo. Neuroscience. 97(2). 243–251. 61 indexed citations
16.
Pevarello, Paolo, Antonio Pillan, Vittorio Pinciroli, et al.. (1999). Pyrrolo[3,2-c]quinoline derivatives: a new class of kynurenine-3-hydroxylase inhibitors. Il Farmaco. 54(3). 152–160. 17 indexed citations
17.
Mantegani, Sergio, et al.. (1998). Serotonergic ergoline derivatives. Bioorganic & Medicinal Chemistry Letters. 8(9). 1117–1122. 4 indexed citations
18.
Giordani, Antonio, et al.. (1998). 4-Phenyl-4-oxo-butanoic acid derivatives inhibitors of kynurenine 3-hydroxylase. Bioorganic & Medicinal Chemistry Letters. 8(20). 2907–2912. 22 indexed citations
19.
Maj, Roberto, Ruggero G. Fariello, Mario Varasi, et al.. (1998). PNU-151774E protects against kainate-induced status epilepticus and hippocampal lesions in the rat. European Journal of Pharmacology. 359(1). 27–32. 49 indexed citations
20.
Speciale, Carmela, Michela Cini, Hui‐Qiu Wu, et al.. (1996). Kynurenic Acid-Enhancing And Anti-Ischemic Effects of the Potent Kynurenine 3-Hydroxylase Inhibitor Fce 28833 in Rodents. Advances in experimental medicine and biology. 398. 221–227. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paolo Pevarello Breakdown of academic impact, for papers by Grazia Lombardi Breakdown of academic impact, for papers by Barbara Costa Breakdown of academic impact, for papers by Francesco G. Salituro Breakdown of academic impact, for papers by Lawrence P. Wennogle Breakdown of academic impact, for papers by Valeria Lucini Breakdown of academic impact, for papers by Shil Patel Breakdown of academic impact, for papers by Sabrina Taliani Breakdown of academic impact, for papers by Anna Partyka Breakdown of academic impact, for papers by David J. Wustrow
Rankless by CCL
2026